Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension

  Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension

Business Wire

BEDFORD, Mass. -- January 28, 2013

Ocular Therapeutix, Inc. announced today it recently closed a Series D
extension round of financing totaling $23.8 million. After considering offers
from several new investors, the decision was made to accommodate the strong
existing investor interest by extending the prior round of financing. All
existing institutional investors, including Polaris Ventures, Versant
Ventures, SV Life Sciences, Sparta LLC, and Ascension Health Ventures
participated at or above their pro-rata level in the current financing.

Ocular Therapeutix will use the funds to further advance development
activities and implementation of clinical trials for its sustained release
drug programs, including travoprost for the treatment of glaucoma, and
dexamethasone for the resolution of post-operative inflammation and pain. The
funds will also be used to support U.S. commercial launch efforts and to
develop sustained release therapies for retinal diseases in collaboration with
pharma partners.

Sustained release drugs offer advantages over current topical ophthalmic
medications by improving patient compliance and eliminating the peaks and
valleys associated with topically-administered drugs, which may improve
disease control and the safety profile of certain drugs.

About Ocular Therapeutix, Inc.:

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA,
focused on the development and commercialization of ophthalmic therapeutic
products using its proprietary hydrogel technology. Ocular Therapeutix is
focusing on development of drug-eluting punctum plugs for treatment of
glaucoma and post-operative inflammation and pain, injectable depots for
back-of-the-eye diseases, and ReSureĀ® Sealant for sealing clear corneal
incisions following lens implantation surgery.


Ocular Therapeutix, Inc.
Scott Corning, 781-357-4000
Vice President of Marketing and Sales
Press spacebar to pause and continue. Press esc to stop.